{"disease":{"id":"pulmonary-arterial-hypertension-pah","name":"pulmonary arterial hypertension pah"},"drugs":{"marketed":[{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."},{"drug_id":"sotatercept","indication_name":"pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winrevair","generic_name":"SOTATERCEPT","company_name":"Merck Sharp Dohme","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":"1443","mechanism":"Winrevair works by binding to and inhibiting the activity of activin receptors, which play a role in the development of pulmonary arterial hypertension."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01347216","title":"COMPERA / COMPERA-KIDS","phase":"","overall_status":"RECRUITING","enrollment_count":14000,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT07217522","title":"Rutgers University Study of the Genetics of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07082933","title":"Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06987097","title":"Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":410,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT03904693","title":"Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Actelion","has_results":true},{"nct_id":"NCT07245680","title":"COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07013149","title":"The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":121,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07314814","title":"Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Prof. Valérie Mc Lin","has_results":false},{"nct_id":"NCT05546125","title":"a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Pfizer Pharmaceuticals Ltd.","has_results":false},{"nct_id":"NCT07318597","title":"Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":99,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05967299","title":"Study of Intravenous ZMA001 in Healthy Subjects","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07266012","title":"Incorporating the Venous Excess Ultrasound Score (VExUS Score) Into Contemporary Haemodynamic Risk Assessment in Pulmonary Arterial Hypertension: The INVEXUS-PAH Study","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT07457762","title":"AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?","phase":"NA","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06454422","title":"Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT06477640","title":"Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension","phase":"NA","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT06819059","title":"Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT07232368","title":"The Effect of Slow-Paced Breathing on Patient Outcomes in Pulmonary Arterial Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT07356375","title":"Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07177703","title":"Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07453030","title":"Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Caio Júlio César dos Santos Fernandes","has_results":false},{"nct_id":"NCT07487441","title":"Reverse Remodeling of the Pulmonary Vasculature: a Longitudinal, Investigational Study of the Effects of Sotatercept.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Franz Rischard, DO","has_results":false},{"nct_id":"NCT05947240","title":"Effects of UE Aerobic Exercise on Exercise Capacity and PA in Patients With Pulmonary Arterial Hypertension.","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT03145298","title":"ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT06658522","title":"Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06917196","title":"PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.","phase":"","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT07357974","title":"Impact of Sotatercept on Pulmonary Artery and Right Ventricle Remodeling Imaging Assessed With 68Ga-FAPI PET/CT in Patients With PAH","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06872112","title":"A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Joseph C. Wu","has_results":false},{"nct_id":"NCT06932198","title":"Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Humanis Saglık Anonim Sirketi","has_results":false},{"nct_id":"NCT03523910","title":"Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT06941441","title":"PAH Exercise Study","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT03362047","title":"(RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT06493461","title":"A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"35Pharma Inc","has_results":false},{"nct_id":"NCT06643143","title":"A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Inhibikase Therapeutics","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}